Suchergebnisse - "Iwasa, Satoru"

PubPharm (362)

1

Correction to : Phase I study of the anti‑TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Yamamoto, N. | Koyama, T. | Sato, J. | +9

ErratumFor: Cancer Chemother Pharmacol. 2024 Jan 11;:. - PMID 38206370

2

Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin

enthalten in: In vivo (Athens, Greece) | 2024

von Yada, M. | Yamamoto, S. | Honma, Y. | +7

3

Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinoma

enthalten in: Esophagus : official journal of the Japan Esophageal Society | 2024

von Hirose, T. | Yamamoto, S. | Honma, Y. | +11

4

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer : Results of the Japanese Expanded Access Program

enthalten in: Clinical colorectal cancer | 2024

von Kotani, D. | Takashima, A. | Kato, T. | +16

5

Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Yamamoto, N. | Koyama, T. | Sato, J. | +9

ErratumIn: Cancer Chemother Pharmacol. 2024 Mar 31;:. - PMID 38556530

6

A telephone follow-up management model for oral outpatient chemotherapy featuring concerted interventions by hospital and community pharmacists, and physicians

enthalten in: ResearchSquare.com | 2023

von Makihara, R. | Hayashi, Y. | Miki, A. | +10

7

Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer : APOLLO-11 study

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Takahari, D. | Katai, H. | Takashima, A. | +18

8

Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors : Results from Phase Ib

enthalten in: Cancer research communications | 2023

von Ida, H. | Shimizu, T. | Nishino, M. | +20

9

Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer : a post hoc analysis of the AXEPT study

enthalten in: Cancer communications (London, England) | 2023

von Iwasa, S. | Wang, Z. | Muro, K. | +6

10

Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF) : Results from the Advanced Gastric Cancer Expansion Cohort

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Shitara, K. | Hirao, M. | Iwasa, S. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]